Temozolomide

Back to search

Molecule Structure

Scientific Name

Temozolomide

Description of the Drug

Temozolomide is an alkylating agent used to treat glioblastoma multiforme and refractory anaplastic astrocytoma.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00853

Brand Name(s)

Temodal, Temodar, Temomedac, Temozolomide

Company Owner(s)

Deva Holding As, Mylan Pharmaceuticals Inc, Lannett Co Inc, Rising Pharma Holdings Inc, Lannett Holdings Inc, Amneal Pharmaceuticals, Chartwell Life Molecules Llc, Merck Sharp And Dohme Corp, Apotex Inc, Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
DNA NUCLEIC-ACID INHIBITOR CHEMBL2311221

Unichem Links

SureChEMBL SCHEMBL3739
PharmGKB PA451609
Human Metabolome Database HMDB0014991
WDI CCRG81045
DrugBank DB00853
PubChem: Thomson Pharma 15171582
PubChem 5394
Mcule MCULE-9414994158
LINCS LSM-4590
Nikkaji J171.234I
BindingDB 50034562
EPA CompTox Dashboard DTXSID5043714
DrugCentral 2589
Brenda 230130 230129 18217
ChemicalBook CB2708199
Guide to Pharmacology 7301
GSRS 1e9bc7f7-58b1-45fe-8540-bb2b23da40b7
rxnorm TEMODAR TEMOZOLOMIDE
PubChem: Drugs of the Future 12013608
ChEBI 72564
NIH Clinical Collection SAM001246636
ZINC ZINC000001482184